BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Strongbridge Biopharma plc Announces New Employment Inducement Awards - Dec. 14, 2017

  The inducement awards are being made in the form of non-qualified stock options to purchase an aggregate of 391,650 ordinary shares of the Company.

  December 14, 2017

   · 

  3 min read
• Business

  Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors

  Dr. Wikler will replace current Board member, Stefano Ferrari, effective January 1, 2018.

  December 14, 2017

   · 

  6 min read
• Drug Development

  Akcea Initiates Phase II Study of AKCEA-ANGPTL3-LRx in Patients With Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)

  The primary goal of the study is to determine the dose level and frequency for use of AKCEA-ANGPTL3-LRx in future registration studies.

  December 14, 2017

   · 

  5 min read
• Genetown

  HSS and pSivida Report Positive Phase I Knee Osteoarthritis Pain Study Data

  The implant was designed to deliver a continuous-low dose of dexamethasone into the knee joint for several months.

  December 14, 2017

   · 

  8 min read
• Genetown

  owancMicrobot Receives Notice of Alle for U.S. Patent Covering Its TipCAT Technology Platform

  This increases the number of issued or allowed patents to 24 and an additional 12 patent applications pending worldwide, covering its ViRob™ and TipCAT™ technology platforms.

  December 14, 2017

   · 

  4 min read
• Pharm Country

  Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors

  The Exchange Offer will expire at 5:00 p.m. (New York time) today, December 14, 2017

  December 14, 2017

   · 

  18 min read
• Galectin Therapeutics Provides Corporate Update at Annual Meeting

  The NASH-CX trial was a randomized, double-blind, placebo-controlled Phase 2b clinical trial which enrolled 162 NASH cirrhosis patients into the treatment phase.

  December 14, 2017

   · 

  7 min read
• Provecs Medical Announces Publication of Scientific Review of Gene Therapy in Oncology

  Provecs Medical GmbH, a cancer immunotherapy company developing novel treatments to modulate the tumor microenvironment, today announced the publication of a review highlighting the use of gene therapy approaches in immuno-oncology to address multiple targets with a single drug.

  December 14, 2017

   · 

  2 min read
• Business

  Mayo Clinic to Begin Prospective Clinical Study With Medibio Technology for Expanded Market Opportunities

  This initial study, undertakes the prospective diagnosis and longitudinal monitoring of both unipolar and bipolar depression, along with the depressive subtypes (melancholic and atypical).

  December 14, 2017

   · 

  3 min read
• Drug Development

  Cellectar Files IND for Phase I Trial of CLR 131 in Pediatric Cancers

  The study will be initiated with the pediatric oncologists and Nuclear Medicine/Radiology Group at The University of Wisconsin Carbone Cancer Center.

  December 14, 2017

   · 

  6 min read